American Diabetes Association and Lilly Announce Creation of Research Awards
June 4, 2013
The American Diabetes Association (Association) and Eli Lilly and Company (NYSE: LLY) are pleased to announce the creation of a three-year collaborative research program aimed at better understanding diabetes care in older adults, many of whom are disproportionately affected by this disease.
The program, “American Diabetes Association and Lilly Clinical Research Award: Diabetes Care in Older Adults,” will grant a total of $1.2 million for targeted research awards and was made possible through funding from Lilly Diabetes. The program will be directed, managed and overseen by the Association.
It is currently estimated that at least 25 percent of people aged 65 and older have diabetes. That percentage is expected to grow as the U.S. population ages. When older adults have diabetes, they are at increased risk of morbid conditions such as depression and cardiovascular disease, adversely affecting their functional status and life expectancy. The Association and Lilly agree that research studies in this population are crucial for several reasons, including ability to assess diabetes risk, ability to assess optimal treatment approaches, ability to assess the care of older patients with multiple co-morbidities, dependent living situations and significant hypoglycemia risk.
“This is an unmet need in diabetes care,” said Robert Heine, Vice President, Medical Affairs, Lilly Diabetes. “Older adults with diabetes often face greater complications and might need different approaches to care and treatment than younger adults. With this research program and with the collaboration of the American Diabetes Association, we hope to be able to delve deeper into the challenges facing this population as they confront this disease.”
The Association is currently seeking research applications for clinical and translational studies focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in the older adult population with diabetes. Deadline for submission is Sept. 16, 2013. The awards will be announced later this year. The grants will be three-year awards starting in early 2014.
For more information, visit professional.diabetes.org/grants.
“As a leader in the fight to Stop Diabetes®, the American Diabetes Association supports research aimed at better understanding how we can prevent, treat and cure diabetes. We are thrilled that Eli Lilly and Company has stepped forward to provide funding support for this program,” said John E. Anderson, MD, President, Medicine & Science, American Diabetes Association. “This research program will provide us with the opportunity to understand clinical approaches that are most effective in addressing diabetes needs and limiting the risk of complications for older adults living with diabetes.”
About the American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association's mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)